BSX Cash Flow Statement
Boston Scientific Corp - Operating, Investing & Free Cash Flow Analysis
Operating Cash Flow
$3.44B
Free Cash Flow
-
FCF per Share
-
CapEx
-
Operating Activities
Cash generated from core business operations
Primary cash generation
Investing Activities
Cash used for investments and capital expenditures
Total investing activities
Financing Activities
Cash from financing activities including debt, equity, and dividends
Total financing activities
Free Cash Flow (FCF) Calculation
Cash Flow Trends (Annual)
| Period | Operating CF | Investing CF | Financing CF | Free CF |
|---|---|---|---|---|
| 2024-12-31 | $3.44B | ($5.69B) | $1.81B | - |
| 2023-12-31 | $2.50B | ($2.57B) | $5.00M | - |
| 2022-12-31 | $1.53B | ($2.01B) | ($548.00M) | - |
| 2021-12-31 | $1.87B | ($1.60B) | ($95.00M) | - |
| 2020-12-31 | $1.51B | ($411.00M) | $293.00M | - |
View Complete Financial Analysis
Full income statements, balance sheets, and detailed cash flow analysis
Open Full AnalysisFrequently Asked Questions
What is BSX free cash flow?
Free cash flow data for BSX is available in the full cash flow statement.
What is BSX operating cash flow?
BSX generated $3.44B in operating cash flow in the most recent period. Operating cash flow shows the cash generated from core business operations.
What is BSX FCF per share?
FCF per share can be calculated by dividing free cash flow by shares outstanding.
Is BSX cash flow growing?
BSX's operating cash flow grew by 37.2% year-over-year.
What is BSX FCF yield?
FCF yield is calculated by dividing free cash flow by market capitalization.
What is BSX capital expenditure?
Capital expenditure data is available in the investing activities section.